NCT05834751 2023-04-28
the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma
The First Hospital of Jilin University
Phase NA Unknown
Clinical Trials
8 trialsNCT00301925 2018-08-08
TACT2
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
NCT02238873 2014-10-02
Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma
Rabin Medical Center
Phase 3 Unknown
NCT00551122 2013-01-23
GemTIP
University of Southampton
Phase 1/2 Unknown
NCT00777673 2013-01-04
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
University of Tennessee Cancer Institute
Phase 2 Unknown
NCT00499018 2011-02-15
DLCL04
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown
NCT00751894 2011-01-19
MEG-5
University Hospital, Clermont-Ferrand
Phase 2 Unknown
NCT00333008 2006-09-26
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.
The Alvin and Lois Lapidus Cancer Institute
Phase 2 Unknown